HHS Public Access

Author manuscript
Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September
Author Manuscript

01.
Published in final edited form as:
Endocrinol Metab Clin North Am. 2016 September ; 45(3): 511–520. doi:10.1016/j.ecl.2016.04.004.

Regarding Obesity as a Disease: Evolving Policies and Their

Implications
Theodore K. Kyle, RPh, MBA,
ConscienHealth, 2270 Country Club Drive, Pittsburgh, PA 15241; 412-205-9303

Emily J. Dhurandhar, PhD, and

Department of Kinesiology and Sport Management, Box 43011, Texas Tech University, Lubbock,
Author Manuscript

TX 79409-3011; 806-834-6556

David B. Allison, PhD

Office of Energetics, Nutrition Obesity Research Center, and Department of Biostatistics,
University of Alabama at Birmingham, Ryals Building, Room 140J, 1665 University Boulevard,
Birmingham, AL 35294; 205-975-9167
Theodore K. Kyle: [email protected]; Emily J. Dhurandhar: [email protected]; David B. Allison:
[email protected]

Synopsis
The 2013 decision of the American Medical Association (AMA) to recognize obesity as a
complex, chronic disease that requires medical attention came as the result of developments over
three decades. Defining a condition such as obesity to be a disease is a very public process that is
Author Manuscript

largely driven by expectation of costs and benefits. Although the public has been slow to embrace
defining obesity as a purely medical condition, evidence is emerging for broader awareness of
factors beyond personal choice influencing obesity. The AMA decision appears to be working in
concert with other factors to bring more access to care, less blame for people with the condition,
and more favorable conditions for research to identify effective strategies for prevention and
clinical care to reduce the impact of this disease.

Keywords
Obesity; health policy; chronic disease; health care economics and organizations; medicalization;
access to healthcare; social stigma
Author Manuscript

Introduction
Perhaps because of the close relationship among physical appearance and obesity,
intertwined with moral beliefs and class discriminations related to obesity, the social and
cultural implications of excess weight have historically received more attention than its
medical implications. Until the mid to late twentieth century in America, undernourishment
and hunger were prioritized as more important public health concerns than was obesity. In

Correspondence to: Theodore K. Kyle, [email protected].

 Kyle et al. Page 2

1950, the first medical society devoted to clinical management of obesity established itself
Author Manuscript

as the National Obesity Society. The organization subsequently changed its name to the
National Glandular Society, the American College of Endocrinology and Nutrition, the
American Society of Bariatrics, the American Society of Bariatric Physicians, and now the
Obesity Medicine Association.1

With the recognition that obesity is responsible for a growing prevalence chronic diseases,
obesity has come to be regarded as “the single greatest threat to public health for this
century.”2 Research has provided a deeper understanding of the genetic, metabolic,
environmental, and behavioral factors that contribute to obesity. This growing evidence base
challenges the dominant public understanding of obesity as a reversible condition resulting
primarily from dietary and lifestyle choices that reflect ignorance or limited motivation.

These developments have led obesity to be increasingly described by scientific and medical
Author Manuscript

experts as a complex chronic disease. This paper will review reasons why obesity is regarded
as a disease and implications of this increasingly dominant perspective.

Defining What Is a Disease

In 2008, the Obesity Society commissioned a panel of experts to consider the question of
labeling obesity a disease and to complete a thorough review of pertinent evidence and
arguments.3 The panel considered three distinct approaches to the question:

1. Scientific. This approach hinges upon two questions. What are the
characteristics that define a disease? And what is the evidence that obesity
possesses those characteristics? The panel found that the scientific
approach was inadequate for answering this question “because of a lack of
Author Manuscript

a clear, specific, widely accepted, and scientifically applicable definition

of ‘disease.’”

2. Forensic. This approach relies upon authoritative statements from

respected organizations declaring that obesity is or should be considered to
be a disease. After an exhaustive search of public statements, the panel
found “is a clear and strong majority leaning – although not complete
consensus – toward obesity being a disease.” However they found that
these statements were largely issued as a matter of opinion and lacked
arguments or evidence to support a determination of “what is true or what
is right.”

3. Utilitarian. This third approach – a logical analysis of the benefits and

Author Manuscript

harms arising from considering obesity a disease – formed the basis for the
panel’s ultimate recommendation.

It follows that the determination of what is a disease is more of a social and policy
determination than it is a scientific determination. Policymakers and experts make reasoned
judgments about whether or not a condition should be considered a disease based upon
evidence, as well as explicit and implicit values. Public acceptance of that judgment (or not)

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.
 Kyle et al. Page 3

represents a final step in this process. Randolph Neese summarized the inherent challenge of
Author Manuscript

defining whether something is a disease:

Our social definition of disease will remain contentious, however, because values
vary, and because the label “disease” changes judgments about the moral status of
people with various conditions, and their rights to medical and social resources.4

Milestones in Regarding Obesity as a Disease and their Policy Implications

Figure 1 depicts milestones in regarding obesity as a disease. Each milestone is an example
of how labeling a condition as a “disease” or “not a disease” can have significant policy
implications. Established in 1977, the Healthcare Financing Administration (HCFA,
predecessor to CMS, the Centers for Medicare and Medicaid Services) included language in
its Coverage Issues Manual stating that “obesity is not an illness.”5 This language reflected
Author Manuscript

widely-held beliefs and served as a model for denying coverage of obesity care under both
publicly and privately funded health plans.

In 1998, the National Institutes of Health published Clinical Guidelines on the Identification,
Evaluation, and Treatment of Overweight and Obesity in Adults that stated, “Obesity is a
complex multifactorial chronic disease.”6

In early 2002, the Internal Revenue Service issued a ruling that expenses for obesity
treatment would qualify as deductible medical expenses.7 Later in 2002, the Social Security
Administration (SSA) published an evaluation of obesity stating that “Obesity is a complex,
chronic disease characterized by excessive accumulation of body fat.”8 This determination
explicitly stated that obesity is a valid medical source of impairment for the purpose of
evaluating Social Security disability claims.
Author Manuscript

A key milestone came in 2004 when CMS removed language stating that “obesity is not an
illness” from its Coverage Issues Manual.5 Although this action did not include a specific
determination that obesity is a disease, it removed a significant obstacle to further progress
and coverage for obesity-related medical services.

In 2006, CMS issued a National Coverage Determination providing coverage for bariatric
surgery under Medicare, a decision that followed as a natural consequence of the agency’s
2004 reassessment of obesity.9

As previously mentioned, the Obesity Society published a white paper on evidence and
arguments for obesity as a disease in 2008, followed in 2012 by a similar position from the
American Association of Clinical Endocrinologists.10
Author Manuscript

Finally, in 2013, the American Medical Association resolved at its annual House of
Delegates meeting to “recognize obesity as a disease state with multiple pathophysiological
aspects requiring a range of interventions to advance obesity treatment and prevention.”11
Though this resolution has no legal standing, the AMA has stated that “recognizing obesity
as a disease will help change the way the medical community tackles this complex issue.”
Their leadership in shifting the care model for obesity to a chronic disease model may have a
significant impact on the way obesity is addressed, as discussed below.

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.
 Kyle et al. Page 4

Initial Public Response to the AMA Decision

Author Manuscript

The AMA decision to recognize obesity as a disease captured considerable public attention
in June of 2013 when it was announced. Though it continued to be discussed and debated
among stakeholders in health and obesity policy, interest from the general public quickly
faded, as indicated by Figure 2, which depicts Google Trends data for Internet search
volume related to obesity and disease.

Much of the public debate about the merits of this decision included three distinct
viewpoints:

1. Relief and Agreement. Clinicians, researchers, and individuals with

obesity expressed relief that obesity was now being seen as a legitimate
health concern, rather than a cosmetic or lifestyle concern. Sarah
Bramblette expressed this perspective in Narrative Inquiry in Bioethics
Author Manuscript

(NIB): “I celebrated the American Medical Association’s classification of

obesity as a disease…I am a real person and deserve the same level of
access to healthcare as other patients.”12

2. Concern about Weight Discrimination. Activists in the Fat Acceptance

and Health at Every Size movements have consistently expressed
opposition to this decision, anticipating that its primary effect would be to
promote size and weight discrimination. In another NIB essay, Jennifer
Hansen expressed this view: “Classifying obesity as a disease provides
more ammunition for the ‘war on obesity.’ From a fat person’s
perspective, the ‘war on obesity’ is a war on fat people.”13

3. Concern about Personal Responsibility. Michael Tanner captured this

Author Manuscript

perspective in the National Review: “At first glance, it’s a minor story,
hardly worth mentioning, but in reality the AMA’s move is a symptom of
a disease that is seriously troubling our society: the abdication of personal
responsibility and an invitation to government meddling.”14

Research on public perception of obesity following the AMA decision suggests a shift away
from the dominant view that obesity is a personal problem of bad choices (Figure 3).
However, this research does not suggest that the public is increasingly adopting the view that
obesity is a medical problem. Rather, the public is shifting toward a view that obesity is a
community problem of bad food and inactivity.15

These findings are generally consistent with observations by Puhl et al. that public
awareness of the AMA decision is relatively low. Nonetheless, their study documented more
Author Manuscript

public agreement with statements in support of describing obesity as a disease than with
statements opposing it.16

Potential Effects of Regarding Obesity as a Disease

In the 2008 white paper commissioned by the Obesity Society, the authors concluded:

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.
 Kyle et al. Page 5

Considering obesity a disease is likely to have far more positive than negative
Author Manuscript

consequences and to benefit the greater good by soliciting more resources into
research, prevention, and treatment of obesity; by encouraging more high-quality
caring professionals to view treating the obese patient as a vocation worthy of effort
and respect; and by reducing the stigma and discrimination heaped upon many
obese persons.

Two years after the decision by AMA to recognize obesity as a disease, assessing the effects
of that decision against expectations is a worthwhile exercise, albeit one that involves a
substantial degree of subjective judgments. Certainly, many factors are at work in changes
observed since the AMA decision.

Public understanding of obesity has arguably improved, as measured by a decline in the

dominant view that obesity is simply a personal problem of bad choices. Likewise, the
Author Manuscript

research of Puhl and Liu suggests that the public is more supportive of this view of obesity
than opposed to it.16 Still, public opinion is more focused on risk factors related to the food
supply and physical activity than on the medical aspects of obesity.15 This may be a
reflection of the complexity of a disease that remains a challenge to both researchers and
healthcare professionals.

Stigma is a prevalent problem for people living with obesity17 and the evidence for any
changes in this phenomenon is mixed. One manifestation of stigma is the idea that “fat
shaming”, or shaming people with obesity about their weight, will help the individual lose
weight. This approach has received considerable attention in popular media and online
social networks in the years since AMA designated obesity as a disease. Fat shaming was
hardly recognized before 2012, but interest in the subject has grown dramatically. Assigning
the label of “fat shaming” to this idea inherently positions explicit bias against people with
Author Manuscript

obesity as socially unacceptable.

While explicit shaming of people with obesity may be increasingly rejected, it is not clear
that the prevalence of weight bias is changing. In fact, research by the Obesity Action
Coalition finds increasing social discomfort with people who have obesity.15

Prevention efforts might best be described as experiencing no discernible change in the two
years since the AMA decision. Writing in Lancet this year, Roberto et al. describe “patchy
progress” in obesity prevention with only “isolated areas of improvement.”18

Experimental data published in 2014 suggested that describing obesity as a disease could
undermine prevention efforts through a negative effect on self-regulation of dietary
behavior.19
Author Manuscript

Treatment options for obesity have expanded significantly, with the introduction of four
new drugs and three devices. FDA has developed a more explicit framework for evaluating
benefit/risk tradeoffs for new obesity treatments.20 Research on new treatment options
appears to be growing and multiple national health organizations are working together on
guidelines and advocacy for obesity care.21

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.
 Kyle et al. Page 6

Insurance reimbursement remains a significant problem for both patients and providers in
Author Manuscript

obesity care. Nonetheless, some changes have occurred that will influence coverage for
obesity care. In 2014, the federal Office of Personnel Management issued guidance to health
plans for federal employers that they could no longer exclude obesity care by characterizing
obesity as a lifestyle or cosmetic condition. In 2015 the National Conference of Insurance
Legislators resolved that state legislatures should provide for “coverage of the full range of
obesity treatment.”22

Medical education has received significant attention from the Bipartisan Policy Center in a
report issued in June 2014.23 In addition, work of the Obesity Society to identify gaps in
testing for obesity-related competencies on medical board examinations has resulted in a
commitment to address the gaps.24 Finally, although it has not yet passed, legislation entitled
the ENRICH ACT has been introduced to provide grants to medical schools for
incorporating obesity education into their curriculum.25
Author Manuscript

Consumer protection against fraudulent weight loss products remains a significant

problem. Noteworthy actions against dietary supplements by state attorneys general and the
U.S. Justice Department have been taken in the last year.26 The Obesity Society, the Obesity
Medicine Association, the Obesity Action Coalition, and the Academy of Nutrition and
Dietetics recently issued a joint position calling for more stringent regulation of dietary
supplements that make therapeutic claims for obesity.27

Discrimination in employment has received increased attention following the AMA

decision. Employment law firms have issued opinions that this ruling could create additional
risk for employers who discriminate against people with obesity, and the EEOC has won
additional rulings that obesity can be considered a protected disability under the Americans
Author Manuscript

with Disabilities Act.28

Credibility of obesity research and care is difficult to observe directly. It is worth noting that
the numbers of physicians taking the certification examination of the American Board of
Obesity Medicine has grown dramatically in the years since the AMA decision. The number
applying to take the exam in 2015 grew by 27%, which might be taken as evidence of
growing credibility for the emerging specialty of obesity medicine.29 In addition, the
Commission on Dietetic Registration is preparing to offer a certification examination in
obesity and weight management for allied health professionals.30

Implications for Obesity Research

The National Institutes of Health has recognized that obesity is a chronic disease since 1998,
Author Manuscript

and this is reflected in the Strategic Plan for NIH Obesity Research released by the NIH
Obesity Task Force in 2011.31 The main highlights of the research agenda outlined include a
need for more probative research to better understand the fundamental causes of obesity, to
develop new and more effective treatments for obesity, to empirically test strategies for
obesity prevention in the real-world settings for which they are intended, and to improve
technology to overcome many challenges in obesity research. This agenda demonstrates

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.
 Kyle et al. Page 7

acknowledgement of a chronic and relatively unaddressed disease that is still in great need
Author Manuscript

of further probative research to improve outcomes.

However, whether or not progress is being made on this probative research agenda, and if
the AMA decision to recognize obesity as a disease has influenced the research agenda and
resources for obesity research thus far, is unclear. Ultimately, this research agenda
demonstrates insightful leadership and is well informed, but will not influence which
research is conducted until individuals participating in the grant review process view obesity
as a disease.

If strides in the medicalization of obesity treatment through improved education in medical

schools and insurance coverage of treatments following the decision continue to progress,
this may eventually lead to more demand for, and better coordination of, data collection on
evidence-based care models. Similarly, if the disease decision continues to lessen the view
Author Manuscript

that obesity is an issue of personal responsibility, this may eventually be reflected in the
treatment and prevention approaches that are being pursued through research.

Summary
Defining what is and is not a disease is necessarily a pragmatic decision. A clear, objective,
and widely accepted definition of what is and is not a disease – one that adequately captures
things conventionally accepted as diseases and excludes things that are not – is lacking.
Obesity is a highly stigmatized condition that has long been generally regarded by the public
as a reversible consequence of personal choices. As research has documented the genetic,
biological, and environmental factors that play important roles in obesity and its resistance
to treatment, a growing number of medical and scientific organizations have come to regard
obesity as a disease. The decision by the American Medical Association (AMA) in 2013 to
Author Manuscript

recognize obesity as a disease state marked a key milestone in progress toward accepting
obesity as a disease and advancing evidence-based approaches for its prevention and
treatment. Some signs of progress are evident following the AMA decision, although diverse
stakeholders continue to debate the merits of this determination.

References
1. Eknoyan G. A history of obesity, or how what was good became ugly and then bad. Adv Chronic
Kidney Dis. 2006; 13(4):421–7. [PubMed: 17045228]
2. U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th.
Washington, DC: U.S. Government Printing Office; 2010.
3. Allison DB, Downey M, Atkinson RL, et al. Obesity as a disease: a white paper on evidence and
arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring). 2008;
Author Manuscript

16(6):1161–77. [PubMed: 18464753]

4. Nesse RM. On the difficulty of defining disease: a Darwinian perspective. Med Health Care Philos.
2001; 4(1):37–46. [PubMed: 11315418]
5. Tillman, K. National Coverage Analysis (NCA) Tracking Sheet for Obesity as an Illness
(CAG-00108N). CMS.gov. 2004. Available at: https://www.cms.gov/medicare-coverage-database/
details/nca-tracking-sheet.aspx?NCAId=57&TAId=23&IsPopup=y&bc=AAAAAAAAAgAAAA
%3D%3D&. Accessed November 20, 2015

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.
 Kyle et al. Page 8

6. National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation,
Treatment of Overweight and Obesity in Adults. The Evidence Report. Sep. 1998 NIH publication
Author Manuscript

98-4083http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf
7. Anderson, C. Obesity Is Tax Deductible. CBSnews.com. 2002. Available at: http://
www.cbsnews.com/news/obesity-is-tax-deductible/. Accessed November 20, 2015
8. SSA.gov. Social Security Administration Program Operations Manual (POMS) - DI 24570.001
Evaluation of Obesity. 2002. Available at: https://secure.ssa.gov/poms.nsf/lnx/0424570001.
Accessed November 20, 2015
9. Phurrough, S.; Salive, M. Decision Memo for Bariatric Surgery for the Treatment of Morbid Obesity
(CAG-00250R). CMS.gov. 2006. Available at: https://www.cms.gov/medicare-coverage-database/
details/nca-decision-memo.aspx?NCAId=160&ver=32&NcaName=Bariatric+Surgery+for+the
+Treatment+of+Morbid+Obesity+(1st+Recon)&bc=BEAAAAAAEAgA. Accessed November 20,
2015
10. Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical
Endocrinologists’ position statement on obesity and obesity medicine. Endocr Pract. 2012; 18(5):
642–8. [PubMed: 23047927]
Author Manuscript

11. Pollack, A. AMA Recognizes Obesity as a Disease. NYTimescom. 2013. Available at: http://
nyti.ms/1Guko03. Accessed November 20, 2015
12. Bramblette S. I am not obese. I am just fat. Narrat Inq Bioeth. 2014; 4(2):85–8. [PubMed:
25130338]
13. Hansen J. Explode and die! A fat woman’s perspective on prenatal care and the fat panic epidemic.
Narrat Inq Bioeth. 2014; 4(2):99–101. [PubMed: 25130343]
14. Tanner, M. Obesity Is Not a Disease. National Review Online. 2013. Available at: http://
www.nationalreview.com/article/352626/obesity-not-disease-michael-tanner. Accessed November
20, 2015
15. Kyle, T.; Thomas, D.; Ivanescu, A., et al. Indications of Increasing Social Rejection Related to
Weight Bias. Presented at: ObesityWeek; November 2, 2015; Los Angeles, CA. Available at:
http://conscienhealth.org/wp-content/uploads/2015/10/Bias-Study-Report.pdf. Accessed
November 20, 2015
16. Puhl RM, Liu S. A national survey of public views about the classification of obesity as a disease.
Obesity (Silver Spring). 2015; 23(6):1288–95. [PubMed: 25970728]
Author Manuscript

17. Puhl, R.; Kyle, T. Pervasive Bias: An Obstacle to Obesity Solutions. National Academy of
Medicine. 2014. Available at: http://nam.edu/perspectives-2015-pervasive-bias-an-obstacle-to-
obesity-solutions/. Accessed November 20, 2015
18. Roberto CA, Swinburn B, Hawkes C, et al. Patchy progress on obesity prevention: emerging
examples, entrenched barriers, and new thinking. Lancet. 2015; 385(9985):2400–9. [PubMed:
25703111]
19. Hoyt CL, Burnette JL, Auster-gussman L. “Obesity is a disease”: examining the self-regulatory
impact of this public-health message. Psychol Sci. 2014; 25(4):997–1002. [PubMed: 24463553]
20. Ho MP, Gonzalez JM, Lerner HP, et al. Incorporating patient-preference evidence into regulatory
decision making. Surg Endosc. 2015; 29(10):2984–93. [PubMed: 25552232]
21. Smith, S. AMA Joins Call for Coverage of Obesity Treatments and Medications - TOS Connect.
The Obesity Society. 2014. Available at: http://tosconnect.obesity.org/news/press-releases/new-
item2. Accessed November 21, 2015
22. National Conference of Insurance Legislators. NCOIL Legislotors Adopt Resolution Encouraging
Author Manuscript

Coverage For Obesity Treatment. 2015. Available at: http://www.ncoil.org/HomePage/

2015/07292015ObesityResolutionPR.pdf. Accessed November 20, 2015
23. Glickman, D.; Shalala, D. Teaching Nutrition And Physical Activity In Medical School: Training
Doctors For Prevention-Oriented Care. Washington, DC: Bipartisan Policy Center; 2014. Available
at: http://bipartisanpolicy.org/wp-content/uploads/sites/default/files/Med_Ed_Report.PDF.
Accessed November 20, 2015
24. Kushner, R.; Butsch, S.; Aronne, L., et al. Review of Obesity-Related Items on the United States
Medical Licensing Examination (USMLE) Examinations for Medical Students: What is Being

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.
 Kyle et al. Page 9

Tested?. Presented at: ObesityWeek; November 2, 2015; Los Angeles, CA. Available at: https://
guidebook.com/guide/48144/poi/4317961/?pcat=185403. Accessed November 20, 2015
Author Manuscript

25. Glickman, D.; Shalala, D. The ENRICH Act will provide better tools to fight obesity epidemic.
TheHill. 2015. Available at: http://thehill.com/blogs/congress-blog/healthcare/236479-the-enrich-
act-will-provide-better-tools-to-fight-obesity. Accessed November 20, 2015
26. Lorenzetti, L. Justice Department Charges Dietary Supplements Maker. Fortune. 2015. Available
at: http://fortune.com/2015/11/17/doj-dietary-supplements/. Accessed November 20, 2015
27. The Obesity Society. Dietary Supplements Sold as Medicinal or Curative for Obesity. 2015.
Available at: http://www.obesity.org/publications/position-and-policies/medicinal-or-curative.
Accessed November 20, 2015
28. Katz, D. Another Judge Finds that Obesity May be a “Disability” Under the ADA (Americans with
Disabilities Act). The National Law Review. 2015. Available at: http://www.natlawreview.com/
article/another-judge-finds-obesity-may-be-disability-under-ada-americans-disabilities-act.
Accessed November 20, 2015
29. Burke, J. Record Number of Physicians to Sit for 2015 ABOM Exam. American Board of Obesity
Medicine. 2015. Available at: http://abom.org/record-number-of-physicians-to-sit-for-2015-abom-
Author Manuscript

exam/. Accessed November 20, 2015

30. Commission on Dietetic Registration. CDR’s New Interdisciplinary Certification in Obesity and
Weight Management. 2015. Available at: https://www.cdrnet.org/interdisciplinary. Accessed
November 20, 2015
31. 17.NIH Obesity Research. Strategic Plan for NIH Obesity Research. 2011. Available at: http://
obesityresearch.nih.gov/about/strategic-plan.aspx. Accessed November 20, 2015
Author Manuscript
Author Manuscript

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.
 Kyle et al. Page 10

Key Points
Author Manuscript

• Defining what is and is not a disease is fundamentally a pragmatic

decision. A clear, objective, and widely accepted definition of what is
and is not a disease – a definition that adequately captures things that
conventionally accepted as diseases and excludes things that are
conventionally not – is lacking.

• Obesity is a highly stigmatized condition that has long been generally

regarded by the public as a reversible consequence of personal choices.

• As research has documented the genetic, biological, and environmental

factors that play important roles in obesity and its resistance to
treatment, a growing number of medical and scientific organizations
have come to regard obesity as a disease.
Author Manuscript

• The decision by the American Medical Association (AMA) in 2013 to

recognize obesity as a disease state marked a key milestone in progress
toward accepting obesity as a disease and advancing evidence-based
approaches for its prevention and treatment.

• Some signs of progress are evident following the AMA decision,

although diverse stakeholders continue to debate the merits of this
determination.
Author Manuscript
Author Manuscript

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.
 Kyle et al. Page 11
Author Manuscript
Author Manuscript

Figure 1. Milestones toward Considering Obesity to Be a Disease

Large open circles represent key milestones; smaller circles represent other noteworthy
milestones.
Author Manuscript
Author Manuscript

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.
 Kyle et al. Page 12
Author Manuscript

Figure 2. Interest over Time in “Obesity Disease”

The vertical axis is an index of the relative popularity (measured by number of searches) for
the search term (obesity disease), compared to all Internet searches completed on Google at
a given time. Source: Google Trends Internet Search Index.
Author Manuscript
Author Manuscript
Author Manuscript

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.
 Kyle et al. Page 13
Author Manuscript
Author Manuscript

Figure 3. Trend in Public Perception that Obesity Is a “Personal Problem of Bad Choces”
Between Feb 2013 and Mar 2015, the proportion of the public that views obesity primarily
as a “personal problem of bad choices” declined modestly (p=0.0004, binomial regression)
from 44% to 36%. Adapted from Kyle et al.15
Author Manuscript
Author Manuscript

Endocrinol Metab Clin North Am. Author manuscript; available in PMC 2017 September 01.